Guangdong Biolight Meditech Co Ltd
Guangdong Biolight Meditech Co Ltd is a medical equipment and supplies company that generates revenue through the production and distribution of healthcare products.
Business. Guangdong Biolight Meditech Co Ltd (300246.SZ) is a healthcare services and equipment company engaged in the medical equipment, supplies, and distribution industry. The firm operates on a product-sale revenue model, focusing on the development and sale of medical devices and related supplies. Headquartered in China, the company is primarily listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Guangdong Biolight Meditech Co Ltd (300246.SZ) is a healthcare services and equipment company engaged in the medical equipment, supplies, and distribution industry. The firm operates on a product-sale revenue model, focusing on the development and sale of medical devices and related supplies. Headquartered in China, the company is primarily listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.
Guangdong Biolight Meditech Co Ltd has a debt-to-equity ratio of 0.64, indicating a moderate level of leverage, and a current ratio of 1.59, suggesting it has sufficient short-term assets to cover its liabilities. However, the company's free cash flow is negative at -187.96 million CNY, and capital expenditures are -167.46 million CNY, indicating ongoing investment in operations but also a drain on liquidity.
The company's profitability is weak, with a return on equity of -6.1% and a return on assets of -2.75%, both significantly below the industry norms for medical equipment and supplies firms. This underperformance is reflected in its operating and net losses, with operating income at -72.62 million CNY and net income at -69.43 million CNY.
Geographically, the company's revenue concentration is not disclosed in the available data, but its business is primarily focused on the Chinese market. Segment-wise, the company operates as a single entity, with no disclosed business segments, which may limit diversification and risk mitigation.
Looking ahead, the company's growth trajectory is uncertain. With a negative net income and operating income, it is unclear whether the company will achieve profitability in the near term. The financial data does not provide specific outlook figures for the current or next fiscal year.
The company faces several risk factors, including liquidity concerns due to negative free cash flow and significant capital expenditures. The risk assessment indicates a medium liquidity risk and a low dilution risk, with no immediate pressure for equity issuance. The company's capital structure and financial performance suggest a need for careful monitoring of its liquidity and profitability.
Recent events and filings do not provide specific details on the company's strategic initiatives or financial performance beyond the disclosed financial figures. The company's 10-K or equivalent filings would be necessary to understand the management's outlook and any recent developments.
- Guangdong Biolight Meditech Co Ltd is experiencing financial distress with negative operating and net income.
- The company's liquidity is under pressure due to negative free cash flow and high capital expenditures.
- The company's return on equity and return on assets are significantly below industry norms.
- The company's financial performance and growth trajectory are uncertain, with no clear path to profitability.
- The company's risk profile is moderate, with a medium liquidity risk and low dilution risk.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Guangdong Biolight Meditech Co Ltd Market data — financials · 2026-05-26